New CDC data reveals a concerning rise in severe obesity among U.S. adults, with women and middle-aged individuals most affected. The obesity epidemic continues to strain the healthcare system with ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Still, the adult obesity rate in the U.S. is 42.4% vs. 14% in China—though it’s expected to rise along with interest in fast ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

Ultraprocessed food consumption in preschoolers is associated with increased body fat, particularly in boys, underscoring the ...

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...